Addex Therapeutics Ltd (ADXN)

NASDAQ: ADXN · IEX Real-Time Price · USD
6.05
+0.20 (3.42%)
At close: Dec 29, 2023, 4:00 PM
6.00
-0.05 (-0.83%)
After-hours: Dec 29, 2023, 4:15 PM EST

Total Valuation

ADXN has a market cap or net worth of $9.20 million. The enterprise value is $3.94 million.

Market Cap 9.20M
Enterprise Value 3.94M

Important Dates

The last earnings date was Wednesday, November 29, 2023, before market open.

Earnings Date Nov 29, 2023
Ex-Dividend Date n/a

Share Statistics

ADXN has 1.52 million shares outstanding.

Shares Outstanding 1.52M
Owned by Insiders (%) n/a
Owned by Institutions (%) 7.40%
Float n/a

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 4.11
Forward PS n/a
PB Ratio 1.96
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 1.76
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 2.97, with a Debt / Equity ratio of 0.08.

Current Ratio 2.97
Quick Ratio 2.56
Debt / Equity 0.08
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -33.41

Financial Efficiency

Return on equity (ROE) is -238.30% and return on invested capital (ROIC) is -260.03%.

Return on Equity (ROE) -238.30%
Return on Assets (ROA) -147.80%
Return on Capital (ROIC) -260.03%
Revenue Per Employee $93,393
Profits Per Employee -$514,085
Employee Count 24
Asset Turnover 0.27
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -51.98% in the last 52 weeks. The beta is 1.61, so ADXN's price volatility has been higher than the market average.

Beta (1Y) 1.61
52-Week Price Change -51.98%
50-Day Moving Average 5.87
200-Day Moving Average 10.98
Relative Strength Index (RSI) 56.84
Average Volume (30 Days) 8,794

Short Selling Information

Short Interest 3,627
Short Previous Month 4,155
Short % of Shares Out 0.05%
Short % of Float n/a
Short Ratio (days to cover) 0.42

Income Statement

In the last 12 months, ADXN had revenue of $2.24 million and -$12.34 million in losses. Loss per share was -$0.18.

Revenue 2.24M
Gross Profit 2.45M
Operating Income -13.18M
Pretax Income -13.49M
Net Income -12.34M
EBITDA -12.73M
EBIT -13.09M
Loss Per Share -$0.18
Full Income Statement

Balance Sheet

The company has $5.65 million in cash and $384,118 in debt, giving a net cash position of $5.26 million or $3.46 per share.

Cash & Cash Equivalents 5.65M
Total Debt 384,118
Net Cash 5.26M
Net Cash Per Share $3.46
Equity / Book Value 4.69M
Book Value Per Share 3.08
Working Capital 4.53M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$12.40 million and capital expenditures -$6,698, giving a free cash flow of -$12.41 million.

Operating Cash Flow -12.40M
Capital Expenditures -6,698
Free Cash Flow -12.41M
FCF Per Share -$19.88
Full Cash Flow Statement

Margins

Gross margin is 109.30%, with operating and profit margins of -588.21% and -550.45%.

Gross Margin 109.30%
Operating Margin -588.21%
Pretax Margin -601.65%
Profit Margin -550.45%
EBITDA Margin -568.15%
EBIT Margin -584.17%
FCF Margin -553.73%

Dividends & Yields

ADXN does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Earnings Yield -134.07%
FCF Yield -134.87%
Dividend Growth (YoY) n/a
Payout Ratio n/a
Buyback Yield -97.79%
Shareholder Yield -97.79%

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Revenue Growth Forecast (5Y) 19.20%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

The last stock split was on October 23, 2023. It was a reverse split with a ratio of 1:20.

Last Split Date Oct 23, 2023
Split Type Reverse
Split Ratio 1:20

Scores

ADXN has an Altman Z-Score of -84.31 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -84.31
Piotroski F-Score 3